These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11783047)

  • 1. [No documented therapeutic effect of immunoglobulin in severe sepsis and septic shock. Cochrane review is a shot that hit the post!].
    Gårdlund B; Sjölin J
    Lakartidningen; 2001 Dec; 98(49):5623-4. PubMed ID: 11783047
    [No Abstract]   [Full Text] [Related]  

  • 2. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of corticosteroids in septic shock.
    Burry LD; Wax RS
    Ann Pharmacother; 2004 Mar; 38(3):464-72. PubMed ID: 14970369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
    Turgeon AF; Hutton B; Fergusson DA; McIntyre L; Tinmouth AA; Cameron DW; Hébert PC
    Ann Intern Med; 2007 Feb; 146(3):193-203. PubMed ID: 17283351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirror, mirror on the wall, which is the fairest meta-analysis of all?
    Werdan K
    Crit Care Med; 2007 Dec; 35(12):2852-4. PubMed ID: 18043202
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of IgM-enriched immunoglobulin in adult patients with sepsis.
    Kakoullis L; Pantzaris ND; Platanaki C; Lagadinou M; Papachristodoulou E; Velissaris D
    J Crit Care; 2018 Oct; 47():30-35. PubMed ID: 29886064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic decisions based on meta analyses].
    Komossa K; Kissling W; Leucht S; Möller HJ
    Psychiatr Prax; 2008 Nov; 35(8):373-5. PubMed ID: 19016212
    [No Abstract]   [Full Text] [Related]  

  • 9. The safety and efficacy of the use of vasopressin in sepsis and septic shock.
    Wilson SJ; Mehta SS; Bellamy MC
    Expert Opin Drug Saf; 2005 Nov; 4(6):1027-39. PubMed ID: 16255662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of Cochrane collaboration for evidence-based medicine].
    Gøtzsche PC
    Lakartidningen; 2000 Jun; 97(26-27):3180-2. PubMed ID: 10925578
    [No Abstract]   [Full Text] [Related]  

  • 11. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
    Neugebauer EA
    Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations.
    Poulton B
    Int J Antimicrob Agents; 2006 Feb; 27(2):97-101. PubMed ID: 16417989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More evidence that timing matters in the treatment of patients with sepsis.
    Sevransky J
    Crit Care Med; 2008 Oct; 36(10):2932-3. PubMed ID: 18812795
    [No Abstract]   [Full Text] [Related]  

  • 14. [Critical analysis of noninflammatory treatments of sepsis: lessons learned from previous trials].
    Montravers P; Lasocki S; Seguin P; Malledant Y
    Ann Fr Anesth Reanim; 2007 Apr; 26(4):363-9. PubMed ID: 17336486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin therapy of no value in sepsis according to a large clinical trial].
    Gårdlund B
    Lakartidningen; 2002 Mar; 99(13):1456-7, 1460. PubMed ID: 11989356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine in clinical sepsis: a difficult marriage.
    Spapen H
    Crit Care; 2004 Aug; 8(4):229-30. PubMed ID: 15312203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose control in sepsis.
    Thompson BT
    Clin Chest Med; 2008 Dec; 29(4):713-20, x. PubMed ID: 18954705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can my severe sepsis and septic shock patients wait any longer?
    Holthaus CV; Cannon C; Elkin R; Nguyen HB
    Ann Emerg Med; 2009 Jul; 54(1):135-6. PubMed ID: 19541050
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial.
    Soares MO; Welton NJ; Harrison DA; Peura P; Shankar-Hari M; Harvey SE; Madan J; Ades AE; Rowan KM; Palmer SJ
    Crit Care; 2014 Dec; 18(6):649. PubMed ID: 25434816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of levosimendan in sepsis and septic shock.
    Pinto BB; Rehberg S; Ertmer C; Westphal M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.